A monthly oral contraceptive

Natazia®: a New Combination Oral Contraceptive

JALYN® (DUTASTERIDE/TAMSULOSIN): A NEW OPTION IN BPH n the U.S., the leading method of contraception is the combination oral contraceptive pill. More than 10 million women aged 15-44 years use the birth control pill as their primary method of contraception.1 Since the first BCP approval in 1960, the FDA has approved many oral contraceptive products. Most of these products use ethinyl estradiol ...

A practice audit of oral contraceptive users.

Oral contraceptive study--epidemiological principles.

An important cause of the incidence of ill-health in women, as well as of its continuation where established, has for many centuries been excessive fertility. By 'excessive', we mean beyond that desired in the relevant context. Thus, the concept of individual fertility control (the 'fifth freedom') has become as important an argument for contraception as the more general need for population con...

The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.

BACKGROUND So far, no-one has attempted to evaluate the overall balance of serious, but not necessarily fatal, disease among a cohort of oral contraceptive users. AIM To emprirically assess the balance of risk of serious illness among a cohort of oral contraceptive users followed up for up to 28 years. METHODS Oral contraceptive-associated serious disease was defined as that which is often ...

Evaluation of cerebral venous thrombosis risk following oral contraceptive use: A case report and update.

Background and Objectives: The aim of the present study was to report a case of cerebral venous thrombosis (CVT) folowing consumption of the oral contraceptive pills with high estrogen levels. Case Report: A 35-year-old woman presenting a headache was diagnosed with thrombosis in the upper sagittal, sigmoid and transverse  veins, by CT SCAN, MRI and MRV of the brain. Conclusion: The chance ...